Jump to content

Epoetin alfa

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 194.251.240.116 (talk) at 08:32, 24 November 2007 (→‎External links). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Epoetin alfa
Legal status
Legal status

Epoetin alfa (rINN) (IPA: ?) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen.

See also

Superscript text==External links==

References

  1. ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Epoetin_alfa&oldid=173437715"